1-5 of 5
Authors: Luigi Troiani
Journal Article
Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis Get access
The Journal of Immunology, Volume 187, Issue 6, September 2011, Pages 3431–3437, https://doi.org/10.4049/jimmunol.1100580
Published: 15 September 2011
Journal Article
B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis Get access
The Journal of Immunology, Volume 186, Issue 7, April 2011, Pages 4518–4526, https://doi.org/10.4049/jimmunol.1000271
Published: 01 April 2011
Journal Article
B-cells are a therapeutic target for IFNβ in relapsing-remitting multiple sclerosis (167.17) Get access
The Journal of Immunology, Volume 186, Issue 1_Supplement, April 2011, Page 167.17, https://doi.org/10.4049/jimmunol.186.Supp.167.17
Published: 01 April 2011
Journal Article
TLR7 and TLR9 9 agonists enhance the exogenous IFNb-1a’s induction of immunomodulatory cytokine secretion via reconstituting a deficient IFNAR/TLR7 signaling in patients with relapsing remitting multiple sclerosis (164.16) Get access
The Journal of Immunology, Volume 186, Issue 1_Supplement, April 2011, Page 164.16, https://doi.org/10.4049/jimmunol.186.Supp.164.16
Published: 01 April 2011
Journal Article
Activated IL-1R1 Signaling Pathway Induces Th17 Cell Differentiation in Patients with Relapsing Remitting Multiple Sclerosis (83.18) Get access
The Journal of Immunology, Volume 184, Issue Supplement_1, April 2010, Page 83.18, https://doi.org/10.4049/jimmunol.184.Supp.83.18
Published: 01 April 2010
